WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search

QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01X OTHER ANTINEOPLASTIC AGENTS
QL01XX Other antineoplastic agents
QL01XX01 amsacrine
QL01XX02 asparaginase
QL01XX03 altretamine
QL01XX05 hydroxycarbamide
QL01XX07 lonidamine
QL01XX08 pentostatin
QL01XX10 masoprocol
QL01XX11 estramustine
QL01XX16 mitoguazone
QL01XX18 tiazofurin
QL01XX23 mitotane
QL01XX24 pegaspargase
QL01XX27 arsenic trioxide
QL01XX29 denileukin diftitox
QL01XX33 celecoxib
QL01XX35 anagrelide
QL01XX36 oblimersen
QL01XX37 sitimagene ceradenovec
QL01XX40 omacetaxine mepesuccinate
QL01XX41 eribulin
QL01XX44 aflibercept
QL01XX51 talimogene laherparepvec
QL01XX52 venetoclax
QL01XX53 vosaroxin
QL01XX57 plitidepsin
QL01XX58 epacadostat
QL01XX59 enasidenib
QL01XX62 ivosidenib
QL01XX66 selinexor
QL01XX67 tagraxofusp
QL01XX69 lurbinectedin
QL01XX70 axicabtagene ciloleucel
QL01XX71 tisagenlecleucel
QL01XX72 tazemetostat
QL01XX73 sotorasib
QL01XX74 belzutifan
QL01XX91 tigilanol tiglate
QL01XX92 verdinexor

Last updated: 2022-02-03